Tridek-One – new member
Tridek-One is a biotechnology company focused on developing first in class immunomodulatory products targeting the CD31 pathway.
Read moreC.RIS Pharma – new member
C.RIS Pharma is a french Contract Research Organization (CRO), GLP certified, specialized in preclinical development of new active molecules against human diseases.
Read moreAlderaan Biotechnology – new member
The mission of Alderaan Biotechnology is to develop novel therapies to treat cancer by targeting cells from the immune system.
Read moreLicense and Commercialization agreement between Pierre Fabre and ValenzaBio
The US biopharmaceutical company ValenzaBio and the French pharmaceutical group Pierre Fabre announced today the signing of a license agreement of a preclinical insulin-like growth factor-1 receptor (IGF-1R) antagonist antibody, for the treatment of Thyroid Eye Disease (TED).
Read morePLL-Therapeutics – new member
PLL-THERAPEUTICS is working to deliver total solutions for Inflammation, neurodegenerative and autoimmune diseases.
Read more